Literature DB >> 8356618

Risk factors for end-stage renal disease among minorities.

R Ferguson1, E Morrissey.   

Abstract

Blacks, Hispanics, and American Indians are at increased risk of ESRD. Among blacks, hypertension, type II DM, and possibly type I DM are classic risk factors and pose an increased risk for disease. A unifying concept in both DM and hypertension appears to be increased glomerular pressures. The role of diuretics as an independent risk factor for ESRD is further advanced. At a minimum diuretics appear not to be renal protective. Glomerulonephritis also occurs more commonly in blacks. The underlying pathology is largely unknown. There is an increased rate of HAN- and HIV-associated nephropathy which does not explain the excess risk. Patterns of referral or other biases may be in effect. The increased incidence of ESRD in Hispanics is mainly related to DM although, hypertension also plays a role. There is also evidence that HIV-associated nephropathy may occur relatively more often than in whites. We have alluded to the increased incidence of ESRD among American Indians and noted that diabetes mellitus occurs more commonly in most tribal groups while glomerulonephritis occurs more frequently in the Zuni. That groups at increased risk of ESRD are at the lower spectrum of the SES raises this issue as a common risk factor for disease. It is unlikely that SES is an independent risk factor. Education, access to early interventions, and social behavioral factors must be incorporated into any model which proposes a reduction in the rate of ESRD in these groups. The treatment of hypertension with medications that may be renal protective or pose increased risk, especially insofar as diuretics are concerned, must be considered urgent grounds for future research.

Entities:  

Mesh:

Year:  1993        PMID: 8356618

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  7 in total

1.  Race and kidney disease: the scope of the problem.

Authors:  Keith C Norris; Lawrence Y Agodoa
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

Review 2.  Principles of drug administration in renal insufficiency.

Authors:  Y W Lam; S Banerji; C Hatfield; R L Talbert
Journal:  Clin Pharmacokinet       Date:  1997-01       Impact factor: 6.447

3.  Community outreach: a call for community action.

Authors:  Paul Crawford; Randall Maxey; Keith Dacosta
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

4.  Kidney disease in elderly minorities.

Authors:  Chamberlain I Obialo; Sharon Allison-Ottey
Journal:  J Natl Med Assoc       Date:  2002-08       Impact factor: 1.798

5.  Measuring and using admixture to study the genetics of complex diseases.

Authors:  Indrani Halder; Mark D Shriver
Journal:  Hum Genomics       Date:  2003-11       Impact factor: 4.639

6.  Racial Differences in the Effectiveness of a Multifactorial Telehealth Intervention to Slow Diabetic Kidney Disease.

Authors:  Elizabeth A Kobe; Clarissa J Diamantidis; Hayden B Bosworth; Clemontina A Davenport; Megan Oakes; Anastasia-Stefania Alexopoulos; Jane Pendergast; Uptal D Patel; Matthew J Crowley
Journal:  Med Care       Date:  2020-11       Impact factor: 3.178

7.  Melatonin attenuates hypertension-induced renal injury partially through inhibiting oxidative stress in rats.

Authors:  Yu-Feng Qiao; Wen-Juan Guo; Lu Li; Shan Shao; Xi Qiao; Jin-Jin Shao; Qiong Zhang; Rong-Shan Li; Li-Hua Wang
Journal:  Mol Med Rep       Date:  2015-11-02       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.